one of the Best Places to Work in PA for 2010. The awards program,
created in 2000, is one of the first statewide programs of its kind in the
country. The program is a public/private partnership between the Team
Pennsylvania Foundation, the Pennsylvania Department of Community and
Economic Development, and the Central Penn Business Journal.
This survey and awards program was designed to identify, recognize, and
honor the best places to be employed in Pennsylvania, benefiting the state's
economy, its workforce, and businesses.
Companies from across the state entered the two-part process to determine
the 100 Best Places to Work in PA. The first part of this process was
evaluating each nominated company's workplace policies, practices,
philosophies, systems, and demographics. The second part consisted of an
employee survey to measure the employee experience. The combined scores
determined the top companies and the final ranking. Best Companies Group
managed the overall registration and survey process.
Jim Murphy, President of Almac's Clinical Technologies' business unit,
comments on receiving the award: "Almac is honored to receive the Best Places
to Work in PA Award for the second year in a row. Almac's core values are
Quality, Service, Innovation, and People. Among these values, 'people' is the
most critical because Almac's employees are the key to our ability to fulfill
the other three core values. In recognition of this fact, Almac invests
heavily in employment development and fosters a culture that creates a
positive, collaborative, and productive working environment."
Almac's Clinical Technologies unit will be recognized at the Best Places
to Work in PA evening awards ceremony on Tuesday, November 30, 2010, at the
Lancaster County Convention Center in Lancaster, PA. Rankings will be
revealed at the ceremony.
W: http://www.almacgroup.com Page: 1 2 3 4 5 6 7 Related biology technology :1
. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure2
. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy3
. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug4
. Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members5
. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients6
. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone7
. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours8
. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/9
. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases10
. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting11
. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications